Healthcare provider profile · identity verified

Sreenu Ada, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1134171200

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	395	49
Atorvastatin Calcium	Atorvastatin Calcium	310	63
Furosemide	Furosemide	290	51
Levothyroxine Sodium	Levothyroxine Sodium	274	38
Pantoprazole Sodium	Pantoprazole Sodium	235	50
Amlodipine Besylate	Amlodipine Besylate	234	46
Gabapentin	Gabapentin	216	40
Potassium Chloride	Potassium Chloride	172	29
Sertraline Hcl	Sertraline Hcl	161	27
Metoprolol Tartrate	Metoprolol Tartrate	141	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	32
Metoprolol Succinate	Metoprolol Succinate	126	27
Tamsulosin Hcl	Tamsulosin Hcl	118	30
Lisinopril	Lisinopril	116	17
Jardiance	Empagliflozin	110	11
Trazodone Hcl	Trazodone Hcl	101	22
Clopidogrel	Clopidogrel Bisulfate	100	16
Mirtazapine	Mirtazapine	98	30
Oxycodone Hcl	Oxycodone Hcl	97	28
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	93	31
Tramadol Hcl	Tramadol Hcl	92	19
Levetiracetam	Levetiracetam	90	21
Escitalopram Oxalate	Escitalopram Oxalate	89	13
Quetiapine Fumarate	Quetiapine Fumarate	85	19
Lorazepam	Lorazepam	74	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	12
Donepezil Hcl	Donepezil Hcl	67	13
Warfarin Sodium	Warfarin Sodium	67	suppressed
Myrbetriq	Mirabegron	62	suppressed
Losartan Potassium	Losartan Potassium	61	15
Carvedilol	Carvedilol	60	14
Omeprazole	Omeprazole	57	16
Carbidopa-Levodopa	Carbidopa/Levodopa	54	suppressed
Memantine Hcl	Memantine Hcl	53	suppressed
Alprazolam	Alprazolam	50	11
Amiodarone Hcl	Amiodarone Hcl	50	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Metformin Hcl	Metformin Hcl	49	11
Ropinirole Hcl	Ropinirole Hcl	47	suppressed
Entresto	Sacubitril/Valsartan	45	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	24
Bumetanide	Bumetanide	43	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	suppressed
Midodrine Hcl	Midodrine Hcl	39	11
Hydralazine Hcl	Hydralazine Hcl	36	11
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Prednisone	Prednisone	34	13
Spironolactone	Spironolactone	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Allopurinol	Allopurinol	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Xarelto	Rivaroxaban	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	13
Famotidine	Famotidine	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Anastrozole	Anastrozole	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Fentanyl	Fentanyl	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Nystatin	Nystatin	25	16
Atenolol	Atenolol	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	12
Fluvoxamine Maleate	Fluvoxamine Maleate	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Temazepam	Temazepam	21	suppressed
Finasteride	Finasteride	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Zenpep	Lipase/Protease/Amylase	20	suppressed
Phenobarbital	Phenobarbital	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Torsemide	Torsemide	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Levofloxacin	Levofloxacin	17	13
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	12
Scopolamine	Scopolamine	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Linzess	Linaclotide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Risperidone	Risperidone	14	suppressed
Exemestane	Exemestane	13	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Santyl	Collagenase Clostridium Hist.	13	11
Aripiprazole	Aripiprazole	12	suppressed
Budesonide	Budesonide	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clonidine Hcl Er	Clonidine Hcl	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error